Clinical Research Directory
Browse clinical research sites, groups, and studies.
Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening
Sponsor: Abramson Cancer Center at Penn Medicine
Summary
This is a 3-year pragmatic, randomized clinical trial among average-risk patients at diverse primary care practices who are overdue for colorectal (CRC) screening. This project aims to evaluate the effect of a centralized program that includes direct outreach to patients and visit-based, clinician directed nudges facilitated by the electronic health record (EHR) with follow-up text messaging on the uptake of CRC screening. The primary outcome is CRC screening completion at 3 years. Patient and clinician factors impacting the experience and effectiveness of the intervention will be explored through surveys and qualitative interviews.
Key Details
Gender
All
Age Range
50 Years - 72 Years
Study Type
INTERVENTIONAL
Enrollment
20000
Start Date
2023-06-07
Completion Date
2026-12-21
Last Updated
2025-09-05
Healthy Volunteers
No
Conditions
Interventions
No Direct Patient Outreach
Patient will not receive direct outreach prompting them to schedule and/or complete colorectal cancer screening.
Direct Patient Outreach: Colonoscopy Only
Patient will receive direct outreach including an order to schedule and complete colonoscopy.
Direct Patient Outreach: Sequential Choice
Patient will receive direct outreach including an order to schedule and complete colonoscopy then an at-home fecal immunochemical test (FIT) if colonoscopy is not completed.
Visit-Based Nudge/Text
Patient's clinician will receive an alert prompting them to discuss colorectal cancer screening with their patient upon visit. Patient will also receive a text message 3 days after visit reminding them to complete colorectal cancer screening.
No Nudge/Text
Patient's clinician will not receive an alert prompting them to discuss colorectal cancer screening with their patient upon visit. Patient will not receive a text message 3 days after visit reminding them to complete colorectal cancer screening.
Locations (1)
Penn Medicine
Philadelphia, Pennsylvania, United States